2015
DOI: 10.1016/j.ejmech.2015.02.005
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and assessment of the antioxidant and antitumor properties of asymmetric curcumin analogues

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
34
0
2

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 63 publications
(37 citation statements)
references
References 35 publications
1
34
0
2
Order By: Relevance
“…The synthesized compounds (2a-d) were evaluated for antioxidant activity using the 2,2-diphenyl-2-picrylhydrazyl (DPPH) free radical scavenging method, according to a procedure reported previously, with slight modifications [8,14]. Quercetin and curcumin were used as the standards.…”
Section: Antioxidant Activitymentioning
confidence: 99%
See 1 more Smart Citation
“…The synthesized compounds (2a-d) were evaluated for antioxidant activity using the 2,2-diphenyl-2-picrylhydrazyl (DPPH) free radical scavenging method, according to a procedure reported previously, with slight modifications [8,14]. Quercetin and curcumin were used as the standards.…”
Section: Antioxidant Activitymentioning
confidence: 99%
“…Several series of symmetrical monocarbonyl analogs of curcumin (MACs), containing a cyclohexanone or cyclopentanone linker between the two phenyl rings, reportedly have superior anti-inflammatory and antioxidant activity, higher chemical stability, and improved pharmacokinetic profiles compared to curcumin [3,4]. On the other hand, several asymmetrical MAC (AMACs) reportedly exhibit potent anti-inflammatory, antioxidant, and antitumor activities [5][6][7][8]. Finally, our group reported that, while AMACs containing a morpholine Mannich base exhibit low antioxidant activity, two compounds exhibit potent anti-inflammatory activity [9].…”
Section: Introductionmentioning
confidence: 99%
“…Our previous findings have revealed that terminal basic nitrogen-containing heteroaromatic rings are obviously beneficial to the enhanced cytotoxic and anti-proliferative potency and that the 1,5-diheteroarylpenta-1,4-dien-3-one is the most promising class of curcumin-based anti-prostate cancer agents, with the most potent compounds being over 100 folds more potent than curcumin against prostate cancer cell lines [6,7]. Most monoketone curcumin mimics are symmetric with two identical terminal aromatic rings, but a few of recent reports suggest that asymmetric monoketone curcumin mimics might exhibit more desirable biological profile as compared to the corresponding symmetric counterparts [10,11]. All 1,5-diheteroarylpenta-1,4-dien-3-ones previously reported by us are symmetric with two identical terminal nitrogen-containing heteroaromatic rings [7], but we have noticed from our previous data that different terminal heteroaromatic rings can bring in varied benefits to the scaffold of 1,5-diheteroarylpenta-1,4-dien-3-one.…”
Section: Introductionmentioning
confidence: 99%
“…Nowadays, some of the asymmetrical MACs (AMACs) with different constituents on the two phenyl rings have been developed and reported to show antioxidant, anti-inflammatory, antimicrobial [11][12][13][14][15] and antitumor properties [16]. However, the study of the Mannich bases of AMACs as an anti-cancer agent has never been reported.…”
Section: Introductionmentioning
confidence: 99%